BISECCO, Alvino
 Distribuzione geografica
Continente #
EU - Europa 6.885
AS - Asia 3.111
NA - Nord America 2.757
SA - Sud America 506
Continente sconosciuto - Info sul continente non disponibili 280
AF - Africa 46
OC - Oceania 7
AN - Antartide 1
Totale 13.593
Nazione #
RU - Federazione Russa 4.381
US - Stati Uniti d'America 2.674
IT - Italia 1.079
SG - Singapore 974
CN - Cina 642
HK - Hong Kong 546
IE - Irlanda 483
BR - Brasile 404
VN - Vietnam 404
DE - Germania 181
GB - Regno Unito 169
KR - Corea 138
AT - Austria 132
JP - Giappone 110
IN - India 109
FR - Francia 94
UA - Ucraina 79
SE - Svezia 63
NL - Olanda 48
TR - Turchia 48
AR - Argentina 46
FI - Finlandia 43
CA - Canada 34
GR - Grecia 32
MX - Messico 29
BD - Bangladesh 28
BE - Belgio 21
PL - Polonia 20
IQ - Iraq 17
EC - Ecuador 16
CO - Colombia 13
ID - Indonesia 13
ES - Italia 11
PH - Filippine 11
PK - Pakistan 11
ZA - Sudafrica 11
MA - Marocco 9
IR - Iran 8
PY - Paraguay 8
AU - Australia 7
CL - Cile 7
EG - Egitto 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
SA - Arabia Saudita 6
CH - Svizzera 5
LT - Lituania 5
VE - Venezuela 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DZ - Algeria 4
ET - Etiopia 4
IS - Islanda 4
JM - Giamaica 4
KE - Kenya 4
NI - Nicaragua 4
PT - Portogallo 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
JO - Giordania 3
KZ - Kazakistan 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
AM - Armenia 2
BG - Bulgaria 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
SM - San Marino 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
AQ - Antartide 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
HU - Ungheria 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
Totale 13.311
Città #
Moscow 1.610
Hong Kong 525
Dublin 481
Singapore 464
San Jose 361
Santa Clara 331
Ashburn 177
Chandler 173
Naples 159
Ho Chi Minh City 139
Seoul 137
Jacksonville 128
Vienna 119
Hefei 114
Beijing 102
Hanoi 96
Los Angeles 94
Ann Arbor 80
New York 74
Bengaluru 65
Caserta 65
Rome 57
Princeton 56
Roxbury 52
The Dalles 52
Dallas 50
Milan 43
Medford 42
São Paulo 41
Bremen 40
Munich 40
Council Bluffs 34
Napoli 33
Aversa 25
Nuremberg 24
Da Nang 23
Nanjing 23
Norwalk 23
London 22
Orem 22
Brussels 21
Wilmington 21
Amsterdam 20
Haiphong 18
Woodbridge 18
Stockholm 17
Memphis 16
Warsaw 15
Cambridge 14
Atlanta 13
Boardman 13
Chicago 13
Frankfurt am Main 13
Tokyo 13
Chennai 12
Des Moines 12
Falkenstein 12
Miami 12
Montreal 12
Phoenix 12
San Francisco 12
Verona 12
Genoa 11
Mexico City 11
Rio de Janeiro 11
Turin 11
Turku 11
Guangzhou 10
Baghdad 9
Brooklyn 9
Istanbul 9
Jinan 9
Reggio Emilia 9
Thái Bình 9
Bologna 8
Brasília 8
Casoria 8
Florence 8
Helsinki 8
Hải Dương 8
Lappeenranta 8
Manchester 8
Quarto 8
San Polo 8
Seattle 8
Boston 7
Ercolano 7
Johannesburg 7
Mumbai 7
Ninh Bình 7
Sala Consilina 7
Shanghai 7
Afragola 6
Belo Horizonte 6
Denver 6
Guayaquil 6
Houston 6
Padova 6
Porto Alegre 6
Rimini 6
Totale 6.821
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 667
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 223
Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia 215
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 211
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 209
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 199
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 195
Cognitive impairment in CKD patients: a guidance document by the CONNECT network 189
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 181
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 179
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study. 178
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 177
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 176
Apathy Is Correlated with Widespread Diffusion Tensor Imaging (DTI) Impairment in Amyotrophic Lateral Sclerosis 176
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 173
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 169
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 166
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod 162
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? 161
Translational research on cognitive impairment in chronic kidney disease 160
Preliminary results of the FASM study, an on-going italian active pharmacovigilance project 160
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 159
Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS) 157
A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene 155
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 152
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 150
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 148
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 148
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 146
Chemotherapy-related cognitive impairment and kidney dysfunction 144
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 144
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 143
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis 143
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 141
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis 141
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 140
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 139
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 139
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab 138
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis 138
Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population 137
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod 137
Functional gradients reveal cortical hierarchy changes in multiple sclerosis 133
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study 133
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 133
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 133
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis 131
Consensus of algorithms for lesion segmentation in brain MRI studies of multiple sclerosis 130
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 130
Signs and symptoms of COVID-19 in patients with multiple sclerosis 129
Use of Transglutaminase 2 mRNA expression in peripheral blood mononuclear cells in patients with Radiologically Isolated Syndrome as a neuroinflammation biomarker: A preliminary study. 129
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 126
Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation study 125
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 125
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs 123
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: A MAGNIMS Study 123
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 123
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents 122
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 122
Frontotemporal degeneration in amyotrophic lateral sclerosis (ALS): A longitudinal MRI one-year study 122
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study 120
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 120
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey 118
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 118
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability 118
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: The importance of intrathecal MOG-IgG synthesis 116
The relationship between biological sex, cognitive reserve, and cognition in multiple sclerosis 113
Functional plasticity of the visual system in multiple sclerosis. 113
Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study 113
Readability Analysis of Online Headache and Migraine Information 113
Longitudinal assessment of cognitive function in patients with non-relapsing MOG-IgG associated disease 111
Microstructural correlates of Edinburgh Cognitive and Behavioural ALS Screen (ECAS) changes in amyotrophic lateral sclerosis 111
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders 109
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set 109
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study 107
Impact of post-contrast MRI in the definition of active multiple sclerosis 105
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 105
Two Unexpected Cases of Rosacea during Fingolimod Therapy 104
Resting state functional MRI brain signatures of fast disease progression in amyotrophic lateral sclerosis: a retrospective study 101
Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study. 100
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 100
Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study 95
Relation of sensorimotor and cognitive cerebellum functional connectivity with brain structural damage in patients with multiple sclerosis and no disability 95
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 90
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study 88
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis 88
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience 88
Listening to the neurological teams for multiple sclerosis: the SMART project 87
Lifespan normative data on rates of brain volume changes 86
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 85
Psychological resilience explains functional variability across people with multiple sclerosis – Commentary 81
Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study 78
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) 77
Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap 69
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 63
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody–Associated Disease 61
More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis 61
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 58
Cholinergic system in patients with chronic kidney disease: cognitive and renal implications 45
The role of the intestinal microbiome in cognitive decline in patients with kidney disease 44
Totale 13.420
Categoria #
all - tutte 42.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022506 0 20 15 23 123 22 34 23 32 61 37 116
2022/2023867 100 14 23 54 82 57 3 38 439 18 16 23
2023/2024671 36 24 39 75 143 73 63 20 13 16 78 91
2024/20251.904 18 20 27 67 316 234 222 138 286 261 179 136
2025/20268.159 358 492 428 358 673 4.067 688 347 246 230 188 84
2026/2027334 136 198 0 0 0 0 0 0 0 0 0 0
Totale 13.593